Verona, Italy

Elena Tibaldi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitá Degli Studi Di Padova. Active years: 2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elena Tibaldi: Innovator in Antitumoral Compounds

Introduction

Elena Tibaldi is a notable inventor based in Verona, Italy. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumoral agents. Her work focuses on innovative compounds that have the potential to treat various forms of cancer.

Latest Patents

Elena Tibaldi holds a patent for a 1-phenylpropanone compound, which is described as having the formula (I). This compound includes specific elements where X can be CH or an atom selected from the group consisting of O, S, and Se. The integer n ranges from 4 to 6, and A is a substituent selected from a group that includes 4-morpholyl, 1-piperidinyl, and 4-methyl-1-piperazinyl. The invention is particularly significant for its use as an antitumoral agent in the treatment of breast cancer, chronic lymphatic leukemia, or neuroblastoma. The patent also encompasses new 1-phenylpropanone compounds and their applications as antitumoral agents.

Career Highlights

Elena Tibaldi is affiliated with the Università Degli Studi Di Padova, where she conducts her research and development work. Her academic background and research endeavors have positioned her as a key figure in her field.

Collaborations

Elena has collaborated with notable colleagues such as Livio Trentin and Anna Maria Brunati. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.

Conclusion

Elena Tibaldi's work in developing antitumoral compounds showcases her dedication to advancing medical science. Her innovative contributions have the potential to make a significant impact in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…